BackAcadia Healthcare Company Overview
Acadia Healthcare Company Inc

Acadia Healthcare Company Target Price

See Acadia Healthcare Company's analyst price targets ($34) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$27.75

Average Target Price

$34.4424.1% upside

9 analysts in the last 4 months

High: $40 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30GuggenheimJason Cassorla$3940.5% upsideOpen
2026-07-30Barclays$3215.3% upsideOpen
2026-07-20GuggenheimJason Cassorla$3836.9% upsideOpen
2026-07-14KeyBanc$4044.1% upsideOpen
2026-07-09UBS$3940.5% upsideOpen
2026-06-03JefferiesBrian Tanquilut$308.1% upsideOpen
2026-05-27KeyBancMatthew Gillmor$308.1% upsideOpen
2026-05-04RBC Capital$3111.7% upsideOpen
2026-05-04Guggenheim$3111.7% upsideOpen
2026-05-01Cantor Fitzgerald$308.1% upsideOpen
2026-04-30Barclays$259.9% downsideOpen
2026-04-20Jefferies$24.511.7% downsideOpen
2026-04-17UBS$3111.7% upsideOpen
2026-02-26Raymond JamesJohn Ransom$259.9% downsideOpen
2026-02-26Leerink PartnersWhit Mayo$2220.7% downsideOpen
2026-02-23GuggenheimJason Cassorla$2220.7% downsideOpen
2026-01-22JefferiesBrian Tanquilut$1545.9% downsideOpen
2026-01-14RBC Capital$1738.7% downsideOpen
2025-12-18Mizuho Securities$1738.7% downsideOpen
2025-12-04BarclaysAndrew Mok$1449.5% downsideOpen
2025-12-03RBC Capital$1931.5% downsideOpen
2025-12-03Cantor Fitzgerald$1738.7% downsideOpen
2025-12-03Raymond JamesSarah James$1738.7% downsideOpen
2025-12-03UBS$2413.5% downsideOpen
2025-12-03KeyBancMatthew Gillmor$259.9% downsideOpen
2025-12-03Leerink Partners$1449.5% downsideOpen
2025-12-03Deutsche BankPito Chickering$2027.9% downsideOpen
2025-11-07Raymond JamesSarah James$2220.7% downsideOpen
2025-10-08KeyBanc$3526.1% upsideOpen
2025-10-03Raymond JamesJohn Ransom$308.1% upsideOpen
2025-08-13Mizuho SecuritiesAnn Hynes$2220.7% downsideOpen
2025-08-13RBC CapitalBen Hendrix$280.9% upsideOpen
2025-05-14KeyBancMatthew Gillmor$5598.2% upsideOpen
2025-03-03RBC Capital$4355% upsideOpen
2024-10-21Leerink PartnersWhit Mayo$87213.5% upsideOpen
2024-09-27BarclaysAndrew Mok$76173.9% upsideOpen
2024-08-01BarclaysAndrew Mok$83199.1% upsideOpen
2024-05-22RBC CapitalFrank Morgan$94238.7% upsideOpen
2024-05-03Mizuho SecuritiesAnn Hynes$70152.3% upsideOpen
2024-04-25Deutsche BankPito Chickering$70152.3% upsideOpen
2022-12-12RBC Capital$93235.1% upsideOpen
2022-08-26Leerink Partners$103271.2% upsideOpen
2022-08-01RBC Capital$94238.7% upsideOpen
2022-08-01Raymond James$100260.4% upsideOpen
2022-07-29Mizuho Securities$78181.1% upsideOpen
2022-07-29Barclays$85206.3% upsideOpen
2022-07-28UBS$90224.3% upsideOpen
2022-06-20Loop Capital MarketsJoseph France$72159.5% upsideOpen
2022-05-05Leerink Partners$95242.3% upsideOpen
2022-05-05Raymond James$85206.3% upsideOpen

Acadia Healthcare Company (ACHC) FAQ

As of the most recent data, ACHC shows a target price of $34. Scroll down for historical charts and peer comparison views.

If Acadia Healthcare Company moved to the average analyst target of $34, shares would be roughly 24.1% higher than $27.75. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Acadia Healthcare Company's earnings trajectory.

Besides this target price page, Stockcircle has Acadia Healthcare Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $34) with ownership activity and broader fundamentals.

Acadia Healthcare Company's target price is $34; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.